Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells

Molecular Medicine Reports
Lei HuangShui Wang

Abstract

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in females worldwide. Chemoresistance has been a major reason for the drug therapy failure. The present study performed a microarray analysis between MCF‑7 and MCF‑7/adriamycin (ADR) cells, and intended to identify long non‑coding (lnc)RNA expression character in drug resistant breast cancer cells. MCF‑7/ADR cells were induced from MCF‑7 cells via pulse‑selection with doxorubicin for 4 weeks, and the resistance to doxorubicin of ADR cells was confirmed by MTT assay. Microarray analysis was performed between MCF‑7 and MCF‑7/ADR cells. Total RNA was extracted from the two cell lines respectively and was transcribed into cDNA. The results of the microarray were verified by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). Gene Ontology (GO) and pathways analysis were conducted to enrich the dysregulated lncRNAs presented in the microarray results. Compared to the MCF‑7 cells, 8,892 lncRNAs were differentially expressed in MCF/ADR cells (absolute fold‑change >2.0). A total of 32 lncRNAs were selected for RT‑qPCR by fold‑change filtering, standard Student's t‑test, and multiple hypothesis testing. Among the dysregulated ln...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 28, 2002·Cancer Cell·Anders H Lund, Maarten van Lohuizen
Mar 10, 2005·International Journal of Cancer. Journal International Du Cancer·Changcun GuoDaiming Fan
May 19, 2006·The New England Journal of Medicine·Kathleen I PritchardUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul L NguyenJay R Harris
Feb 4, 2009·Nature Reviews. Genetics·Tim R MercerJohn S Mattick
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bent EjlertsenNils Brünner
Jul 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ahmedin JemalElizabeth M Ward
Aug 24, 2010·Human Molecular Genetics·Maite Huarte, John L Rinn
Apr 3, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Laleh Amiri-KordestaniSusan E Bates
Apr 2, 2013·Methods : a Companion to Methods in Enzymology·Nicholas E Ilott, Chris P Ponting
Jul 3, 2013·Molecular and Cellular Endocrinology·Nasun Hah, W Lee Kraus
Nov 22, 2013·Breast Cancer Research and Treatment·Kristina P SørensenTorben A Kruse
Nov 26, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Dec 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·Markus WeilerWolfgang Wick
Jan 1, 2014·Biotechnology and Applied Biochemistry·Zhi-Ming XiaoAi-Min Wang
May 30, 2014·The Lancet Oncology·Lei FanPaul E Goss
Oct 29, 2014·International Journal of Cancer. Journal International Du Cancer·Yulei Zhao, Xiaolong Yang
Dec 3, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jianxin LvHui Xie
Dec 4, 2014·Acta Biochimica Et Biophysica Sinica·Peiguo ShiCeshi Chen
Mar 6, 2015·Scientific Reports·Yesim Gökmen-PolarSunil Badve

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
electrophoresis
Feature Extraction
PCR

Software Mentioned

SPSS
GeneSpring GX
MATLAB
Agilent Feature Extraction
Excel

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.